Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Has Consensus Target Price of $100.00

Posted by George Bondi on Oct 29th, 2026

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) have received an average rating of “Moderate Buy” from the twelve brokerages that are currently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $100.00.

Several equities analysts recently weighed in on the stock. Raymond James Financial restated an “outperform” rating and set a $100.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st. BTIG Research reaffirmed a “buy” rating and issued a $105.00 price objective on shares of Merit Medical Systems in a research report on Tuesday, August 11th. Needham & Company LLC reiterated a “buy” rating and issued a $101.00 target price on shares of Merit Medical Systems in a research note on Tuesday, September 29th. Canaccord Genuity Group increased their target price on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Finally, Weiss Ratings upgraded shares of Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, October 12th.

View Our Latest Stock Analysis on MMSI

Hedge Funds Weigh In On Merit Medical Systems

Institutional investors have recently bought and sold shares of the company. Kilter Group LLC purchased a new stake in shares of Merit Medical Systems in the second quarter worth about $25,000. Harbor Investment Advisory LLC bought a new position in shares of Merit Medical Systems in the second quarter valued at approximately $50,000. IFP Advisors Inc grew its stake in Merit Medical Systems by 88.6% during the third quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier’s stock valued at $60,000 after acquiring an additional 326 shares in the last quarter. Pinnacle Wealth Planning Services Inc. grew its stake in Merit Medical Systems by 84.0% during the third quarter. Pinnacle Wealth Planning Services Inc. now owns 784 shares of the medical instruments supplier’s stock valued at $68,000 after acquiring an additional 358 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its stake in Merit Medical Systems by 44.0% during the third quarter. Farther Finance Advisors LLC now owns 890 shares of the medical instruments supplier’s stock valued at $77,000 after acquiring an additional 272 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Performance

MMSI stock opened at $92.21 on Thursday. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The firm has a market cap of $5.51 billion, a PE ratio of 38.10, a P/E/G ratio of 2.33 and a beta of 0.51. The business has a 50 day moving average of $88.65 and a 200-day moving average of $77.09. Merit Medical Systems has a 12-month low of $59.74 and a 12-month high of $94.85.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. Merit Medical Systems’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the company posted $1.01 earnings per share. As a group, sell-side analysts expect that Merit Medical Systems will post 3.84 earnings per share for the current year.

Merit Medical Systems Company Profile

(Get Free Report)

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.